• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白的表达在翻译水平上受铁的调节。

α-Synuclein expression is modulated at the translational level by iron.

作者信息

Febbraro Fabia, Giorgi Marcello, Caldarola Sara, Loreni Fabrizio, Romero-Ramos Marina

机构信息

CNS Disease Modeling Group, Department of Biomedicine, Aarhus University, Aarhus C, Denmark.

出版信息

Neuroreport. 2012 Jun 20;23(9):576-80. doi: 10.1097/WNR.0b013e328354a1f0.

DOI:10.1097/WNR.0b013e328354a1f0
PMID:22581044
Abstract

Several studies have suggested an interaction between α-synuclein protein and iron in Parkinson's disease. The presence of iron together with α-synuclein in Lewy bodies, the increase of iron in the substantia nigra and the correlation between polymorphism of the several genes implicated in iron metabolism and Parkinson's disease, support a role for iron in the neurodegeneration. Analysis of post mortem brains revealed increased amount of insoluble α-synuclein protein despite unchanged/reduced levels of α-synuclein mRNA in Parkinson's disease. Interestingly, on the basis of the presence of a putative iron responsive element in the 5'-UTR, it has been suggested that there is a possible iron-dependent translational control of human α-synuclein mRNA. Considering the similarity between the sequences present in human α-synuclein mRNA and the ferritin iron responsive element, we postulated that iron deficiency would decrease the translation of α-synuclein mRNA. Here we used HEK293 cells treated with iron chelator deferoxamine or ferric ammonium citrate to verify the possible iron-dependent translational control of human α-synuclein biosynthesis. We show that the amount of polysome-associated endogenous human α-synuclein mRNA decreases in presence of deferoxamine. Our data demonstrate that human α-synuclein expression is regulated by iron mainly at the translational level. This result not only supports a role for iron in the translational control of α-synuclein expression, but also suggests that iron chelation may be a valid approach to control α-synuclein levels in the brain.

摘要

多项研究表明,在帕金森病中α-突触核蛋白与铁之间存在相互作用。路易小体中铁与α-突触核蛋白共存、黑质中铁含量增加以及参与铁代谢的多个基因的多态性与帕金森病之间的相关性,均支持铁在神经退行性变中发挥作用。对死后大脑的分析显示,在帕金森病中,尽管α-突触核蛋白mRNA水平未变或降低,但不溶性α-突触核蛋白的含量却增加了。有趣的是,基于5'-非翻译区中存在假定的铁反应元件,有人提出人类α-突触核蛋白mRNA可能存在铁依赖性翻译调控。考虑到人类α-突触核蛋白mRNA中存在的序列与铁蛋白铁反应元件之间的相似性,我们推测缺铁会降低α-突触核蛋白mRNA的翻译。在此,我们使用用铁螯合剂去铁胺或柠檬酸铁铵处理的HEK293细胞,以验证人类α-突触核蛋白生物合成可能存在的铁依赖性翻译调控。我们发现,在去铁胺存在的情况下,多核糖体相关的内源性人类α-突触核蛋白mRNA的量会减少。我们的数据表明,人类α-突触核蛋白的表达主要在翻译水平受铁的调控。这一结果不仅支持铁在α-突触核蛋白表达的翻译调控中发挥作用,还表明铁螯合可能是控制大脑中α-突触核蛋白水平的有效方法。

相似文献

1
α-Synuclein expression is modulated at the translational level by iron.α-突触核蛋白的表达在翻译水平上受铁的调节。
Neuroreport. 2012 Jun 20;23(9):576-80. doi: 10.1097/WNR.0b013e328354a1f0.
2
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.慢性鼻内去铁胺可改善 α-突触核蛋白 rAAV 帕金森病模型的运动缺陷和病理。
Exp Neurol. 2013 Sep;247:45-58. doi: 10.1016/j.expneurol.2013.03.017. Epub 2013 Mar 24.
3
Alteration in alpha-synuclein mRNA expression in Parkinson's disease.帕金森病中α-突触核蛋白mRNA表达的改变。
Mov Disord. 2004 Feb;19(2):162-70. doi: 10.1002/mds.10683.
4
α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.帕金森病、路易体痴呆和阿尔茨海默病患者死后脑中的α-突触核蛋白 mRNA 和可溶性α-突触核蛋白水平。
Brain Res. 2012 Jun 12;1459:71-80. doi: 10.1016/j.brainres.2012.04.018. Epub 2012 Apr 17.
5
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
6
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积:一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
7
Gelsolin co-occurs with Lewy bodies in vivo and accelerates α-synuclein aggregation in vitro.凝胶蛋白与路易体在体内共存,并在体外加速α-突触核蛋白聚集。
Biochem Biophys Res Commun. 2011 Aug 19;412(1):32-8. doi: 10.1016/j.bbrc.2011.07.027. Epub 2011 Jul 21.
8
Generation of ferric iron links oxidative stress to α-synuclein oligomer formation.生成的三价铁离子将氧化应激与α-突触核蛋白寡聚物的形成联系起来。
J Parkinsons Dis. 2011;1(2):205-16. doi: 10.3233/JPD-2011-11040.
9
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.散发性帕金森病患者中α-突触核蛋白mRNA的水平。
Mov Disord. 2006 Oct;21(10):1703-8. doi: 10.1002/mds.21007.
10
Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.与病理性α-突触核蛋白相关的帕金森病机制:药物研发的新靶点
Neuron. 2006 Oct 5;52(1):33-8. doi: 10.1016/j.neuron.2006.09.026.

引用本文的文献

1
Research progress of cell treatment strategy in Parkinson's disease.帕金森病细胞治疗策略的研究进展
Neurosci Appl. 2024 Mar 30;3:104061. doi: 10.1016/j.nsa.2024.104061. eCollection 2024.
2
Lactoferrin as a Candidate Multifunctional Therapeutic in Synucleinopathies.乳铁蛋白作为突触核蛋白病的多功能候选治疗药物。
Brain Sci. 2025 Apr 6;15(4):380. doi: 10.3390/brainsci15040380.
3
The interplay of iron, oxidative stress, and α-synuclein in Parkinson's disease progression.铁、氧化应激和α-突触核蛋白在帕金森病进展中的相互作用。
Mol Med. 2025 Apr 26;31(1):154. doi: 10.1186/s10020-025-01208-3.
4
Epigenetic regulation of iron metabolism and ferroptosis in Parkinson's disease: Identifying novel epigenetic targets.帕金森病中铁代谢和铁死亡的表观遗传调控:寻找新的表观遗传靶点。
Acta Pharmacol Sin. 2025 Mar 11. doi: 10.1038/s41401-025-01499-6.
5
α-Synuclein Iron-Responsive-Element RNA and Iron Regulatory Protein Affinity Is Specifically Reduced by Iron in Parkinson's Disease.在帕金森病中,铁会特异性降低α-突触核蛋白铁反应元件RNA与铁调节蛋白的亲和力。
Biomolecules. 2025 Feb 2;15(2):214. doi: 10.3390/biom15020214.
6
Ferroptosis-A Shared Mechanism for Parkinson's Disease and Type 2 Diabetes.铁死亡:帕金森病和 2 型糖尿病的共同机制。
Int J Mol Sci. 2024 Aug 14;25(16):8838. doi: 10.3390/ijms25168838.
7
Zeolite and Neurodegenerative Diseases.沸石与神经退行性疾病。
Molecules. 2024 Jun 2;29(11):2614. doi: 10.3390/molecules29112614.
8
The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases.铁的讽刺:对神经退行性疾病有多种影响的元素
Int J Mol Sci. 2024 Apr 12;25(8):4269. doi: 10.3390/ijms25084269.
9
Mapping the Research of Ferroptosis in Parkinson's Disease from 2013 to 2023: A Scientometric Review.从 2013 年到 2023 年,帕金森病中铁死亡研究的图谱:科学计量学综述。
Drug Des Devel Ther. 2024 Apr 3;18:1053-1081. doi: 10.2147/DDDT.S458026. eCollection 2024.
10
Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials.多系统萎缩:生物标志物与临床试验的最新进展及新方向
J Neurol. 2024 May;271(5):2324-2344. doi: 10.1007/s00415-024-12269-5. Epub 2024 Mar 14.